Information  X 
Enter a valid email address

Broker Forecast - RBC Capital Markets issues a broker note on Circassia Pharmaceuticals Plc

By BFN News | 02:20 PM | Thursday 24 January, 2019


RBC Capital Markets today reaffirms its sector performer investment rating on Circassia Pharmaceuticals Plc (LON:CIR) and cut its price target to 65p (from 81p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

a d v e r t i s e m e n t